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AKTIVITI ANTIKANDIDA DAN KAJIAN TOKSISITI NANOKAPSUL 
BERISI FE-BOVIN LAKTOFERIN KITOSAN-KALSIUM FOSFAT 
DISELAPUTI ALGINAT 
 
ABSTRAK 
Laktoferin diketahui mempunyai pelbagai aktiviti antimikrob. Penyelidikan ini 
dijalankan untuk mengkaji aktiviti antikandida dan toksisiti secara in vitro, in vivo 
nanokapsul Fe-Lfb berisi kitosan-kalsium fosfat diselaputi Alginat/EUDRAGIT®S 
100 (NCs). Penyaringan aktiviti antimikrob NCs menunjukkan bahawa NCs 
mempunyai aktiviti antikandida yang baik. Kepekatan perencatan minimum (MIC) 
NCs yang diperolehi adalah 500 µg/mL. Kajian profil pertumbuhan menunjukkan 
bahawa NCs boleh merencatkan pertumbuhan Candida albicans USM-K1 (C. 
albicans) pada kepekatan MIC, dua kali MIC dan empat kali MIC. Kajian elektron 
mikroskopi menunjukkan NCs menyebabkan kemusnahan sel-sel yis secara  
gangguan terhadap dinding sel dan membran sel dengan peningkatan masa 
pengeraman sehingga 36 jam. NCs juga merencatkan pertumbuhan tiub-tiub germa 
C. albicans USM-K1. Kajian kokultur sel-sel epitelium dengan C. albicans 
menunjukkan bahawa NCs meningkatkan pembunuhan C. albicans oleh sel-sel 
epitelial mulut. Kajian in vivo menunjukkan NCs berkeupayaan menyebabkan 
pengurangan unit pembentukan koloni (CFU) sampel ginjal mencit yang dijangkiti 
yis daripada  (21.3 ± 1.3) × 104 ke (4120.0 ± 6.4) × 10 (p < 0.05). Ini menunjukkan 
bahawa NCs mempunyai kesan antikandida terhadap C. albicans secara in vivo. 
Pemeriksaan histologi menunjukkan sampel ginjal mencit yang dirawat dengan NCs 
mempunyai struktur dan koordinasi sel yang lebih baik berbanding dengan mencit 
xviii 
 
yang tidak menerima rawatan. Kajian toksisiti dengan menggunakan anak udang brin 
menunjukkan nilai LC50 bagi NCs adalah melebihi 1 mg/mL yang menunjukkan 
bahawa ia adalah tidak toksik. Kajian sitotoksisiti dengan menggunakan kaedah 
MTT juga menunjukkan NCs adalah tidak toksik terhadap sel-sel Vero bukan kanser. 
Kajian genotoksiti melalui ujian komet terhadap sel-sel Vero dan ujian akar Allium 
cepa menunjukkan bahawa NCs tidak mempunyai kesan genotoksik yang signifikan 
pada keadaan kajian yang ditetapkan. Sebagai kesimpulan, NCs adalah agen 
antikandida yang berkesan dan berpotensi sebagai agen terapi untuk kandidiasis. 
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ANTI-CANDIDAL ACTIVITY AND TOXICITY STUDIES OF 
ALGINATE-ENCLOSED CHITOSAN–CALCIUM PHOSPHATE-LOADED 
FE-BOVINE LACTOFERRIN NANOCAPSULES  
 
ABSTRACT 
Lactoferrin has been known to have antimicrobial properties. This research was 
conducted to investigate the anti-candidal activity and toxicity of 
Alginate/EUDRAGIT® S 100-enclosed chitosan–calcium phosphate-loaded Fe-bLf 
nanocapsules (NCs) by in vitro and in vivo study. The screening of NCs for 
antimicrobial activity showed that NCs has good anti-candidal activity. The 
minimum inhibitory concentration (MIC) value of NCs using broth microdilution 
method was found to be 500 µg/mL. The growth profile study demonstrated that the 
NCs at MIC, two times MIC and four times MIC inhibited the growth of Candida 
albicans USM-K1 (C. albicans). The electron microscopy studies showed that NCs 
caused the destruction of yeast cells by disruption of cell wall and cell membrane 
with increase of incubation time until 36 hours. NCs also inhibited germ tube 
formation of C. albicans. Evaluation of vital staining of epithelial cell and C. 
albicans coculture demonstrated that NCs enhanced the killing of  C. albicans by 
epithelial cells. In vivo studies  showed that NCs caused the reduction of colony 
forming unit (CFU) of kidney samples of mice induced with yeast infection from 
(21.3 ± 1.3) × 104 to (4120.0 ± 6.4) × 10 (p < 0.05). This shows that NCs have in vivo 
anticandidal effect. Histological examination of kidney samples of mice treated with 
NCs showed better cell structure and coordination compared to untreated mice. Brine 
shrimp lethality assay showed that the LC50 value of NCs was more than 1 mg/mL 
xx 
 
which indicated that NCs was not toxic. MTT cytotoxicity assay also revealed that 
NCs was not toxic against non-cancerous Vero cell line. Genotoxicity studies by 
comet assay on Vero cells and Allium cepa root assay revealed that the NCs was 
destitute of significant genotoxic effect under experimental conditions. In conclusion, 
NCs has effective anticandidal properties and has the potential as a therapeutic agent 
against candidiasis.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 Overview and Rational of Study 
 
Pathogenic fungi such as Candida albicans are a key contributory agent for 
opportunistic infections. Immunocompromised individuals such as AIDS patients are 
at danger for opportunistic infections, which if not cured properly, contribute to the 
death linked to their disorders. Inadequate availability of effective antifungal drugs 
and the increasing prevalence of this life threatening fungal infection (Magliani et 
al., 2012) have conspired to outgrowth a necessity for developing novel treatment 
options for opportunistic infections by pathogenic fungi such as C. albicans. Fungal 
cells which categorised as eukaryotes shared numerous similarities with mammalian 
cells such as the nucleus contains DNA organized into chromosomes with distinct 
cytoplasmic organelles and biosynthetic pathways similar to mammalian cells. These 
likenesses have made extra problems in the design of antifungal agent with selective 
toxicity to fungal cells (Enoch et al., 2006; Martins et al., 2011). Moreover, fungal 
cells, like various microorganisms are surrounded by cell wall consist of β-glucan, 
chitin and mannoproteins which offer physical support and defence to the cell 
develop additional obstacle in the design of antifungal agent (Georgopapadakou & 
Tkacz, 1995).  The presence of fungal cell wall which is a complex of biopolymers 
made the discovery of antifungal agents remains an important scientific challenge. 
The insoluble polysaccharides in cell wall convey mechanical strength to the fungal 
cell (Cabib et al., 1988). Hence, the fungal cell wall is emerging as an important 
better defined therapeutic target. For example, in C. albicans, it has been proposed 
 2 
 
that β-glucan and chitin are related to the strength and shape of the cell wall, while 
mannoproteins are accountable for the porosity, its antigenicity and adhesion (Cabib 
et al., 1998). As a result, no antifungal drug was available for the cure of fungal 
infections until the encounter of amphotericin B in 1953 (Dutcher, 1968). This was 
followed by the development of many new antifungal agents. However, with the 
advent of the immunocompromised diseases such as AIDS, the growing number of 
patients alive with repressed immune systems and the deficiency of effective 
antifungal agent for the cure of fungal infections, there has been renaissance in the 
awareness in the search for new, safer, and more efficacious antifungal agents to 
battle serious fungal infections (Barrera et al., 2014; Knechtle et al., 2014). 
 
Concomitant with this, most of the consideration has been dedicated to the 
development of an ideal antifungal agent. Therefore, an ideal antifungal agent should 
possess a few characteristics such as target specific, has multiple mode of delivery, 
mainly oral delivery with minimal toxicities or side effects. It is clear that designing 
an antifungal drug that fulfils the above criteria is a key challenge and requires the 
identification of new biological natural products such as lactoferrin. Lactoferrin is a 
multifunctional iron-binding glycoprotein belonging to the transferrin family present 
in mammalian milk. It has also been shown to inhibit a wide range of fungal, 
bacterial, viral, and parasitic pathogens (Jenssen & Hancock, 2009; Leboffe et al., 
2009; Berlutti et al., 2011; Giansanti et al., 2013). The anticandidal mode of action 
of lactoferrin was suggested to be due to cell wall perturbation (Jenssen & Hancock, 
2009), as proved by cryo-scanning electron microscopy study which showed the 
drastic changes in the cell wall, leading to the formation of surface blebs, swelling 
and cell collapse (Xu et al., 1999). Similar damages on cell wall were also reported 
 3 
 
by Nikawa et al. (1993; 1995) after Candida exposure to both human and bovine 
lactoferrin and it was concluded that the anticandidal activity of lactoferrin is due to 
direct contact of the protein with the fungal cell surface (Valenti et al., 1985).  
 
Between the numerous ways of drug administration, oral drug delivery is 
marked as the harmless. But, for development of novel drug molecule there are a lot 
of problems that has to be tackled when drugs are being delivered through 
gastrointestinal tract of human. These include enzymatic action and gut pH, which 
may lead to degradation of this protein. Recent advances in nanotechnology has 
facilitate oral delivery system for better efficacy, such as slow drug delivery, target 
specificity, better efficacy, and less side effects, which are crucial for drug design 
and development. For the past few decades, various formulations of nanoparticles 
have been used to increase therapeutic benefit (Samarasinghe et al., 2012). Earlier 
successful studies have shown efficacy of the bovine lactoferrin against various 
microorganism (Rogan et al., 2006; Mahidhara et al., 2015). Numerous studies that 
have recognised the role of lactoferrin molecules against bacteria, viruses, and fungal 
infections (Baker & Baker, 2005).  
 
Recently, Kanwar et al. (2015) has prepared alginate chitosan calcium 
phosphate nanocapsules (AEC-CCo-CP-NCs), which have been widely used as drug 
carriers. Alginate and chitosan are biodegradable polymers, and calcium phosphate is 
naturally present in teeth therefore are safe to be used as NCs.  
 
In current study, the in vitro and in vivo experiments were carried out using 
an encapsulated Fe-bovine lactoferrin (AEC-CP-Fe-bLf NCs) preparation to 
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investigate its potential in the treatment of C. albicans. The Alginate-enclosed 
chitosan-calcium phosphate-loaded Fe-bovine lactoferrin nanocapsules (NCs) were 
prepared by a combination of nano precipitation and ionic gelation methods by 
Kanwar et al. (2012) with modifications. These NCs have been loaded with bovine 
lactoferrin molecule to protect it from degradation of gut environment. Therefore, 
bioavailability of lactoferrin protein at the site of microbial infection was not altered 
and will show maximum antimicrobial efficacy. Content of Fe-bLf were analysed 
from tissue lysates which showed maximum Fe-bLf concentrations in tumor (two to 
four-fold higher), bone (twofold higher), blood (twofold higher) and intestines 
(twofold higher). These findings demonstrated maximum distribution of fe-bLf and 
NCs in muscle, blood, liver, bone, spleen, kidney, lung and intestine (Kanwar et al., 
2015). The antimicrobial efficacy of NCs has been studied in vivo against pathogenic 
Salmonella Typhimurium using Balb/c mice model (Gupta et al., 2015). These 
success stories have originated the idea to use NCs in treatment of C. albicans 
infections.   
 
Candidiasis is a fungal infection most commonly caused by the dimorphic 
fungus C. albicans. In contrast to other fungal pathogens, C. albicans is a member of 
the normal flora in the gastrointestinal tract (mouth and oropharynx), respiratory 
system and vaginal area. The growth of C. albicans is suppressed by other normal 
flora in the body. However, if the normal flora is being disturbed, Candida can 
multiply rapidly and cause candidiasis. In recent years, Candida species have also 
been identified as nosocomial pathogens (Prescott et al., 2003). Besides that, 
Candida can also be transmitted sexually. A majority of candidal infections involves 
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the skin or mucous membranes. This is because C. albicans is a strict aerobe and 
therefore such surfaces are suitable for its growth.  
 
Previously, lactoferrin was reported to possess antifungal properties against 
C. albicans by Kirkpatrick et al., (1971). Oral candidiasis is linked with impaired 
secretion of lactoferrin by the salivary glands. Patients had as much as 65% 
lactoferrin reduction compared to healthy individuals. Nanoformulation of lactoferrin 
offers various advantages such as sustained release, better efficiency, lesser side 
effects, target specificity and improved delivery (Kanwar et al., 2011). NCs loaded 
with lactoferrin have never been tested against C. albicans by previous researchers;. 
The present study is therefore represent the first study to investigate the effect of 
NCs against C. albicans. Specifically, this work was to analyse the effect of 
nanoformulated (AEC-CCo-CP-bLf-NC) bovine lactoferrin against C. albicans.  
 
Various formulations of nanoparticles are being used as a novel delivery 
system for drugs, proteins, DNA and monoclonal antibodies (Nowrouzi et al., 2010; 
De Jong et al., 2008; Lewinski et al., 2008). Nevertheless, challenges must be 
overcome if the application of nanoformulation is to increase therapeutic benefit and 
to yield improved therapies. In view of the potential applications of nanoformulation 
in the pharmaceutical sector and the rising worries of United States Food and Drug 
Administration (FDA) about the toxic potential of nanoproducts, there is a need to 
study the toxicological effects of nanoproducts. In this research, the toxicity of NCs 
was studied using brine shrimp lethality assay, Allium cepa assay, cell cytotoxicity 
assay and comet assay.  
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1.2 Objectives 
 
The current study was undertaken with the following specific objectives: 
 
(i) To evaluate the in vitro anticandidal activity of Alginate/EUDRAGIT® S 100-
enclosed chitosan–calcium phosphate-loaded Fe-bLf nanocapsules (NCs) against 
Candida albicans;   
(ii) To study the effect of NCs on the morphology of C. albicans by using 
scanning and transmission electron microscopy; 
(iii) To evaluate in vivo and in vitro cell cytotoxicity of the NCs by using brine 
shrimp lethality assay and MTT assay; 
(iv) To evaluate the in vitro and in vivo genotoxicity of the NCs by comet assay and 
Allium cepa assay, and 
(v) To evaluate the in vivo antiactivity of C. albicans by NCs in an animal model. 
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CHAPTER 2 
 LITERATURE REVIEW 
2.1 Candidiasis 
 
 Candidiasis is the most common fungal infection caused by Candida species 
(Hoepelman & Dupont, 1996). Candidiasis include superficial infections of the skin, 
nails and mucous membranes, candidaemia and systemic infections. Vaginal 
candidiasis most commonly infect non-immunocompromised patients whereas 
superficial candidiasi,s infects mostly the oral cavity, is the most common type of 
infection among immunocompromised patients. Oesophagial candidiasis is another 
type of candidiasis which is usually related with serious immunological disorder. 
Oropharyngeal candidiasis is a major concern in patients infected with HIV. 
 
The genus Candida comprises of several species which are pathogenic. C. 
albicans is the main species but other species such as Candida kruseii and Candida 
parapsilosis can also cause disease in humans. Candida tropicalis and Candida 
stellatoida have been reported to cause diseases in animals. C. albicans is a 
dimorphic fungus that has two growth phases (yeast and hyphal form) (Challacombe, 
1994). Yeast is a fungus which reproduces by budding.  
 
C. albicans is commonly found on mucosal membranes of the oral cavity, 
gastrointestinal system and vagina (Hay, 1999). Approximately 90% of yeast isolated 
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from the vagina is C. albicans and the remaining species are most commonly 
Candida glabarata and Candida tropicalis. Non-C. albicans species can cause 
vaginitis and is usually more resistant to conventional treatment. Candida has been 
reported to be the second most common cause of vaginal infection in the United 
States (Sobel, 2010). Approximately 75% of women experience vulvovaginal 
candidiasis at least once during their childbearing years. Besides that, hepatic 
candidiasis has become a more common disease among immunocompromised 
patients (Haron et al., 1987). 
 
The occurrence of vaginal candidiasis among pregnant women is two times 
higher than non-pregnant women (Merkus, 1990). It has been reported that Candida 
strains can be cultured from the vagina in 10% to 20% of pregnant women and the 
occurrence is even higher during late pregnancy. C. albicans is the cause of 
candidiasis in 80% to 90% of the cases. During pregnancy, the treatment of 
candidiasis is vital for the mother to protect the fetus from life-threatening sepsis.  
 
Itraconazole is not suitable for oral treatment of vaginal candidiasis in 
pregnant women due to the potential risk of malformations of the fetus. The use of 
broad spectrum antibacterial drugs for terminal ill patients in intensive care unit have 
led to candidemia and non-mucosal candidiasis in the non-HIV population 
(Hospenthal et al., 2004).  
 
 9 
 
Acute pseudomembranous candidiasis or more commonly known as thrush is 
a common disease among young, elderly and weakened individuals. Acute atrophic 
candidiasis is also known as antibiotic sore mouth because of its common occurrence 
during the antibiotics treatments. Chronic atrophic candidiasis , caused by the 
colonization of Candida species especially among those who wear their dentures day 
and night. Whereas chronic hyperplastic candidiasis is common among the middle 
aged and elderly patients. This condition has a potential risk of cancerous 
transformation. Erythematous candidiasis is a type of candidiasis related to HIV 
infection (Challacombe, 1994). The most common form of oral candidiasis is thrush 
whereby there is an inflammation of oral mucosa with the formation of superficial 
white plaques and ulcers. Initially, the lesions are localised but later spread to entire 
mouth. The lesions can be asymptomatic or with pain, burning sensation and dryness 
of the mouth, loss of taste and difficulty in swallowing (Hoepelman & Dupont, 
1996). In critically ill patients, invasive candidiasis has become an important 
nosocomial infection. It has been reported that C. albicans (>50%) is the main cause 
of invasive candidiasis in Taiwan (Ruan & Hsueh, 2009). 
 
2.2 Antifungal Therapy 
 
 Various classes of antifungal agents are being employed for the treatment of 
fungal infections (Sanglard, 2003). Before the emergence of triazole antifungal drugs 
in the 1980s, the only agent to treat non-mucosal fungal infections was intravenous 
amphotericin B. There was no effective alternative therapy and treatment was limited 
to amphotericin B or without any treatment at all. The emergence of triazole 
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antifungal therapy, fluconazole and itraconazole enabled physicians to select 
alternative antifungal treatment for candidiasis. This began with the emergence of 
acquired immune deficiency syndrome (AIDS) in which the human 
immunodeficiency virus (HIV) was associated with oropharyngeal candidiasis (or 
thrush) and also the severity of thrush and candidal esophagitis that eventually 
progressed to AIDS (Hospenthal et al., 2004). There are not many choices of 
antifungal drugs to treat the increasing occurrence of systemic fungal infections 
despite the introduction of new echinocandin class and addition of triazole antifungal 
drugs (Rogers, 2006). 
 
Clotrimazole is an effective and safe therapy for the treatment of resistant 
esophageal candidiasis (Ginsburg et al., 1981; Collins & Van Sickels, 1983). Besides 
that, fluconazole was reported to be very effective in the treatment of oropharyngeal 
candidiasis (Koks et al., 2002). Apart from that, ketoconazole is an effective oral 
treatment for vaginal candidiasis (Bisschop et al., 1979). Ketoconazole was also 
reported to be effective in the treatment of skin, nail bed and buccal candidiasis 
among immunocompromised individuals (Horsburgh Jr & Kirkpatrick, 1983). 
Intravenous miconazole was used to treat systemic candidiasis in a pair of Siamese 
twins and a premature newborn. The condition of patients in both cases were 
considered to be life-threatening. However, they responded well to the treatment and 
recovered. Therefore, miconazole can be an alternative to amphotericin B for the 
treatment of systemic candidiasis in neonates (Sung et al., 1979). The management 
of candidiasis consists of drug therapy and other measures to treat underlying causes 
(Hay, 1999). 
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 The therapeutic regimen of azole drugs is not effective due to malabsorption,  
interference due to low gastric pH (ketoconazole, itraconazole), interaction with 
other drugs which include rifampicin (itraconazole, fluconazole, ketoconazole) and 
the emergence of resistant strains of C. albicans, Candida krusei and Candida 
glabarata in recent years (Hoepelman & Dupont, 1996). Echinocandin drugs have 
become an important cure for the treatment of invasive candidiasis. In fact, 
echinocandin drugs can be considered as the first-line therapy for candidiasis 
patients. Anidulafungin, micafungin and caspofungin have also been proven effective 
(Kett & Cubillos, 2008). Apart from amphotericin B, fluconazole and itraconazole, 
clinicians can also select echinocandin class of antifungal agent, caspofungin and 
also the new broad spectrum of azole, voriconazole drug. Other options of azole and 
echinocandins are now being tested. Antifungal susceptibility testing plays an 
important role in the choice of antifungal therapy (Hospenthal et al., 2004). 
According to Gibbs (1998), fluconazole is effective and safe in the treatment of 
patients with systemic candidiasis. 
 
 The metabolism of fungal pathogens is altered in several ways when exposed 
to antifungal drugs. Initially, cells try to resist the inhibitory effect of antifungals by 
developing several resistance mechanisms. This enables the growth of cells at a 
higher concentration of antifungal agents compared to normally susceptible cells.  
When the antifungal drug has reached the concentration causing growth inhibition, 
the agent can be determined whether it is fungistatic or fungicidal (Sanglard, 2003). 
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2.3 Antifungal Resistance by Candida species 
 
 The emergence of Candida strains resistant to antifungal agents is commonly 
reported (Pfaller, 1995). The advancement of antifungal therapy can reduce the 
occurrence of candidiasis in some parts of the world but it may also cause the 
emergence of resistant strains in other areas. Resistance to azole drugs is a major 
concern in the treatment of candidiasis. During the initial development of antifungal 
therapy, the only drug reported to be resistant to strains of C. albicans is flucytosine. 
However, resistance to azole drugs has been reported in long-term therapy with 
ketoconazole for the treatment of chronic mucocutaneous candidiasis. Another 
important concern regarding drug resistance is the problem of cross-resistance (Hay, 
1999). The extensive use of fluconazole has resulted in treatment failures. Resistance 
is particularly observed with relapses of oropharyngeal candidiasis among AIDs 
patients and other conditions (Lupetti et al., 2002).  
 
 Cases of thrush that were not responsive to fluconazole or requiring higher 
doses began to be reported. The resistance of Candida krusei to azole antifungals and 
reduced susceptibility of Candida glabarata were indicated during the early stages of 
the study (Hospenthal et al., 2004). Strains of C. albicans demonstrated resistance to 
fluconazole and also cross-resistance to other triazoles. Nystatin, boric acid or 
flucytosine can be used for treating azole resistant infections. Compliant patients' 
failure to respond to therapy and persistent clinical findings of positive yeast culture 
are indication of antifungal resistance (Sobel et al., 1998). This acquired resistance 
frequently occurs in species other than C. albicans. Candida glabarata is the second 
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most common cause of invasive candidiasis and has reduced susceptibility to 
fluconazole compared to C. albicans (Rogers, 2006). 
 
2.4 Alternative Therapy 
 
 Progress of medical sciences comprising the latest techniques such as 
microsurgery, organ transplant, radio and chemotherapy and artificial organs that 
enable fast recovery from diseases for the well-being of humans. Although scientific 
medicine has managed to penetrate many parts of the world,  its ultimate satisfaction 
is yet to be guaranteed. This is due to the undesirable side effects and suffering 
incurred due to drug administrations such as allergies or hypersensitivities which are 
sometimes life-threatening or can result in permanent disability. This is also due to 
the fact that some rural areas do not have advanced medical facilities. There are two 
types of medical systems, namely cosmopolitan medicine and indigenous medicine. 
Indigenous medicine has been used as an alternative to scientific medicine and 
therefore, is known as alternative medicine. Alternative medicine refers to  those 
medicine other than modern scientific medicine. History has proven and will 
continue to show evidence that alternative medicine and complementary medicine 
are complementary. Both have their advantages and play important roles in 
promoting the well-being of mankind (Jingfeng, 1987). The application of alternative 
medicine can reduce the cost of expensive and highly complex health care of modern 
medical science (Aakster, 1986). 
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2.5 Lactoferrin 
 
 Lactoferrin is a 78-80 kDa molecule present in most of the exocrine 
secretions such as milk, colostrum, serum, semen and tears. Hence, being part of the 
body it does not induce any treatment side effects (Kanyshkova et al., 2001). 
Lactoferrin exerts a broad range of antimicrobial properties against various bacteria, 
virus and fungi in vitro. Human and bovine lactoferrin have 69% homologuous in 
their sequences and structurely very similar as observed at the tertiary level (Pierce et 
al., 1991). Lactoferrin contributes its antimicrobial properties as an intact molecule, 
monoferric lobes and active peptides as part of the host defense against microbial 
diseases. Lactoferrin is rich in cationic and hydrophobic antimicrobial peptides 
which could be targeted against microorganisms. These peptides are conserved 
within the polypeptide chain of lactoferrin and are released by proteolytic enzyme 
digestion. Although many antimicrobial peptides from lactoferrin have been found, 
only three have been thoroughly studied. These peptides are LF1-11, lactoferrampin 
and lactoferricin (Figure 2.1). Peptides play an important function in the 
antimicrobial properties of lactoferrin. The antimicrobial properties of cationic 
peptides is because of cytoplasmic membrane disruption of target cells. The presence 
of antimicrobial peptides in one domain of lactoferrin shows that the protein causes 
disruption of membrane integrity which confers its antimicrobial activity (Sinha et 
al., 2013).  
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Figure 2.1: (a) Structure of Lactoferrin Indicating Positions of LF1-11 (blue), 
Lactoferrampin (pink), and Lactoferricin (green) Peptides in the N terminal lobe.   
(b) The Magnified Structure Demonstrating the Position of Peptides in Detail 
Source: (Sinha et al., 2013) 
 
2.6 Nanotechnology  
 
 Nanotechnology provides advantages such as slow or sustained release, target 
specificity, better efficiency, less side effects and enhance the rate of drug delivery 
(Kanwar et al., 2011). Drugs or biomolecules are loaded onto nanocarriers made of 
biocompatible and biodegradable substances such as synthetic proteins, peptides, 
polysaccharides, lipids, nucleotide and biodegradable polymers. Latest research in 
pharmaceutical has caused the development of proteins and peptides for the 
application in the treatment of diseases. Insulin is a protein employed for the 
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treatment of diabetes (Kanwar et al., 2011). Nanoparticles are very useful at the 
molecular level due to the high surface area and the ability to be customized. This 
include the design of nanoparticles to target specific cells and actives sites. Due to 
their small size, nanoparticles are able to pass through gaps that seem cannot be 
penetrated solving the problems relating with oral drug administration. The term 
“nanoparticles” refer to various structures. A few examples that are being studied for 
delivery of drugs include dendrimers, nanocarriers, nanotubes and degradable 
polymer particles. The most crucial property of nanoparticles is the size and size 
distribution. The size of nanoparticles affects the stability of particles, cell uptake, 
rate of drug release, rate of degradation, toxicity and ability of targeting cells (Singha 
& Lilliard, 2009). The small diameter of nanocapsules provides a high ratio of 
surface area to volume which can drastically elevate the bioavailability of any 
nanoformulated drug or protein (Shaikha et al., 2009). 
 
2.6.1 Alginate-Enclosed Chitosan-Calcium Phosphate-Loaded Ferum-Bovine 
Lactoferrin Nanocapsules (NCs)  
 
 Calcium phosphate nanocapsules (NCs) replenish the calcium content which 
is necessary for a healthy body (Kanwar et al., 2012) and has very good 
biocompatibility. Chitosan is a mucoadhesive polymer which has health benefits 
(Gades & Stern, 2005). Due to its mucoadhesive characteristics, it is attracted to the 
internal surface of the digestive tract causing delivery directly to the walls decreasing 
contact to the intestinal fluids which enhances the delivery of the nanoformulated 
drug or protein (Kawashima et al., 1999). The US Food and Drug Administration has 
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declared sodium alginate as safe for oral intake (Tugcu-Demiroz, 2007). Alginate 
and chitosan are polymers which are biodegradable and calcium phosphate is 
naturally occuring in teeth and hence are safe to be utilized in NCs. Bovine 
lactoferrin is loaded onto NCs to protect it from degradation of the gut. As such, the 
bioavailability of lactoferrin at the site of infection does not change and has 
demonstrated optimum efficacy (Kanwar et al., 2008, Kanwar et al., 2012; Kanwar 
et al., 2015). Hence, NCs composed of three layers which are calcium phosphate 
ferum bovine lactoferrin nanocore followed by chitosan coating and then further 
coated with alginate. The alginate coating is to protect the ferum bovine lactoferrin 
from degradation in the stomach acidic condition, considering that alginate in the un-
ionized form only allows diffusion of the protein in a slow rate in a lower pH 
environment (Zhang et al., 2008). In the intestine, the alginate layer is shed off and 
the NCs are absorbed by cells in the intestine. Iron-saturated ferum bovine lactoferrin 
is loaded on the calcium phosphate ceramic nanocore and further coated with 
chitosan and alginate (Figure 2.2A and 2.2B). Spherical size with particle size 
between 300 to 350nm is shown by transmission electron microscope (Figure 2.2C) 
and scanning electron microscopy images (Figure 2.2D). The average size of 
205+15nm for calcium-coated calcium phosphate (CSC) inner core was 
demonstrated that was increased to 322+27.2 following coating with alginate to 
develop the final form of alginate-enclosed chitosan-coated calcium phosphate 
(ACSC).  
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Figure 2.2 : Structural components  of NCs 
(A) & (B) NCs have spherical morphology under, (C) transmission electron 
microscopy, (D ) scanning electron microscopy  
Source: (Mahidhara et al., 2015) 
 
 The stability and size of NCs were studies over a range of pH(2-8) using 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and dynamic light 
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scattering (Mahidhara et al., 2015). NCs demonstrated little degradation at pH2 by 
dynamic light scattering. Only 15% of NCs demonstrated degradation while 85% 
were intact with the size of 300-330 nm. Therefore, their study showed the stability 
of NCs at acidic pH. However, the size of NCs was reduced to 205 nm due to 
shedding of the alginate layer. Their findings showed that an outer coating of 
alginate can protect a large portion (85%) of NCs from acid degradation at pH2, that 
is utilized to mimic the physiological (acidic) condition in the stomach of mice. The 
purpose of using alginate layer is to protect the inner core from degradation in the 
gastrointestinal system and alginate itself is fragmented in the process releasing the 
chitosan-coated calcium phosphate inner core. Therefore, the amount of chitosan-
coated calcium phosphate NCs that have reached the final destination will be 
abundant .  
 
2.7 Antimicrobial Peptide  
 
Antimicrobial peptides (AMPs) are a diverse class of small proteins (12 to 50 
amino acids) that are associated together due to their innate antimicrobial properties. 
Antimicrobial peptides have been discovered several decades ago, but it is only 
recently that their function is emphasized as vital to mammalian immune response 
(Gallo et al., 2002). Antimicrobial peptides are involved in the innate immune 
response and are used as the first line of defense by many organisms such as plants, 
insects, bacteria and vertebrates. Since antimicrobial peptides play a role as effectors 
in the innate immune system, they directly kill a broad range of microorganisms such 
as gram-positive and gram-negative bacteria, fungi and certain viruses. Apart from 
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that, these peptides interact with the host that cause events that complement their 
function as antibiotics. Although important, less emphasis has been put on 
antimicrobial peptides due to its underestimated role in human immunology.  
 
Generally, antimicrobial peptides can be categorized into a few categories on 
the basis of their structures but most of them have a few similar structural features 
which include a cationic charge and the ability to interact with bacterial membranes 
through hydrophobic amino acids. Based on these common characteristics, two main 
families of antimicrobial peptides have been characterized, which are defensins and 
cathelicidins (Gallo et al., 2002). These forms have assisted in determining the 
importance of charge and hydrophobicity as the most vital properties responsible for 
antimicrobial properties (Rotem & Mor, 2009). Antimicrobial peptides are 
widespread in the animal and plant kingdom and play vital roles in defense 
mechanism. There are many varieties of antimicrobial peptides discovered and  
therefore, it is difficult to classify them except on the basis of their secondary 
structure (Zasloff, 2002). 
 
The clinical developments between diseases and the production of 
antimicrobial peptides indicate that these peptides have vital and various functions 
(Gallo et al., 2002). Antimicrobial peptides are natural occurring antibiotics. As these 
peptides are genetically encoded and  the rate of antibiotic resistance is much greater 
compared to mutations in mammals, a question has arisen as to why there is no 
emergence of antibiotic resistance towards peptides. There are various possibilities 
that explain this phenomenon. One of the possibilities is that the mechanism of 
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action of antimicrobial peptides which usually involves the penetration into the 
microbial membrane is considered a niche to the target microorganisms. Therefore, 
the cost for the emergence of resistance outweighs the need to maintain the growth of 
membrane integrity. Another reason for the persistence of antimicrobial properties is 
the combination of the antibiotic functions of peptides and their role as soluble 
immune mediators. Defensins and cathelicidins are chemotactic.  
 
The unique properties of antimicrobial peptides in defense of microorganisms 
and the rise of antibiotic resistance to conventional antibiotics have led to studies in 
the development of antimicrobial peptides. Some of the clinical uses include infected 
diabetic foot ulcers, oral mucositis, meningococcal meningitis, catheter infections, 
acne, cardiac ischemia and fungal infections. Topical applications are likely to have 
the most immediate uses. Clinical studies of these antimicrobial peptides has 
potential benefits in the treatment of inflammatory and infectious diseases (Gallo et 
al., 2002). Antimicrobial peptides are currently employed as antimicrobial 
alternatives to chemical food preservatives and are also commonly used as 
antibiotics. Besides that, they also have potential applications in the pharmaceutical 
and food additive industry (Li et al., 2012).  
 
2.8 Milk Derived Antimicrobial Peptides 
 
HLopt2 (a modified peptide sequence based on amino acid residues 20-31 of 
the N-terminal end of human lactoferrin (hLF) has more potent antifungal properties 
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compared to hLF against all C. albicans and Candida neoformans except for 
Candida glabarata (Kondori et al., 2011). Human lactoferrin is derived from breast 
milk and HLopt2 was synthesized by an automated peptide synthesizer. A percentage 
of propidium iodide positive cells was used to demonstrate permeability of 
cytoplasmic membrane of C. albicans ATCC 64549 incubated with peptides for two 
hours. In another study, treatment of C. albicans and Candida neoformans with 
HLopt2 altered the surface of yeast significantly whereby the surface of C. albicans 
seemed punctured with deep pits and blebs were observed throughout the surface of 
the yeast. In that study, rougher surfaces were observed for Candida neoformans and 
leakage of substances were detected between the cells and the surface was covered 
heavily with blebs. Based on that study, treatment with HLopt2 caused greater than 
99.9% death of yeast cells. In that study, following the two hours treatment of the 
yeast cells with hLF, agglutination of the cells were seen and surface changes of  the 
cells were noticed. A more wrinkled cell surface was observed compared to the 
untreated cells. In addition, they showed that HLopt2 and HLBD1 demonstrated  in 
vivo anticandidal activity in infected mice and there was a significant reduction in 
colony-forming units in the washings from the Candida infected skin in mice at a 
dose of 400 µg/spot by both peptides. The mode of action of peptides in that study 
was the disorganization of the cell wall and disruptions of the cell membrane and 
mitochondrial membrane (Kondori et al., 2011).  
 
In a previous study, the MIC of lactofericcin B, a peptide derived from the 
enzymatic cleavage of bovine lactoferrin was evaluated against nine strains of C. 
albicans (Bellamy et al., 1993). C. albicans was inhibited by lactofericcin B between 
18 to 60 µg/mL (6 to 20 µM) in 1% peptone or PYG medium (Bellamy et al., 1993). 
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That study indicated that C. albicans were highly susceptible to lactofericcin B. 
Comparatively,  the MIC of bovine apo-lactoferrin against the strain JCM1542T in 
1% peptone obtained in that study was 2.0 mg/mL (25 µM) which was less effective 
than its active peptide. The antimicrobial properties against C. albicans decreased in 
the presence of potassium chloride (KCl) or magnesium chloride (MgCl2) in the 
range of 25 to 100 mM or CaCl2 in the range of 1 to 5 mM. Apart from that, 
lactofericcin B caused the colony-forming capabilities of C. albicans to be lost 
rapidly. The rate of killing of the yeast by lactoferricin B was both time and dose 
dependent. The findings showed that C. albicans were highly sensitive to suppresion 
by lactoferricin B indicated that active peptides of lactoferrin can be potential host 
defense against C. albicans infections.  
 
The anticandidal mechanism of lactoferricin B was evaluated whether it has 
direct interaction with the cell surface by determining the cell-binding abilities of 
14C-labeled lactoferricin B (Bellamy et al., 1993). It was found that the peptide 
bound to C. albicans and maximum binding happened in 60 minutes under the set 
conditions of cells in 25 mM potassium phosphate buffer, pH 6.0 were treated with 
14C-labelled lactoferricin B at 30 oC. The rate of binding was found to be 
proportional to the rate of killing caused by lactoferricin B. It showed that the extent 
of binding was dose dependent and the number of molecules bound was about 2.3 × 
108/cell at the highest peptide concentration of 150 μg/mL. This number for the 
binding to specific protein receptors is greater than  expected  indicating that this 
peptide can interact with repeated parts of the cell surface. The degree of binding 
decreased in the presence of Mg2+ and Ca2+ ions as both helped to reduce the 
anticandidal properties of lactoferricin B. The findings indicated that cell-binding 
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played an important function in the anticandidal action of lactoferricin B. Thus 
suggested the involvement of ionic interactions in cell-binding. The degree of 
binding was pH dependent and optimum binding was at pH 6.0.  The killing effect of 
lactofericcin B was maximum at the optimum pH for cell binding. This further 
supports the finding that cell binding was vital for the lethal effect of C. albicans.  
 
It was found that the peptide caused a dramatic alteration in cell morphology 
when the ultrastructural structures of the yeast were examined by transmission 
electron microscope. Organelles were no longer noticeable following 60 minutes of 
treatment while peptide debris in the cytoplasm gradually increased during the 
duration of treatment. This indicated that lactoferricin B may cause autolysis in C. 
albicans. Findings of their  study exhibited a correlation between cell-binding and 
the killing effect of lactoferricin B against the yeast. Therefore, it can be concluded 
that direct interaction with the cell surface contributed to the anticandidal 
mechanism. The findings of their study that lactoferricin B caused a killing effect 
against C. albicans indicated that the structural component of lactoferrin responsible 
for anticandidal activities is the region corresponding to this active peptide (Bellamy 
et al., 1993).   
 
Lactoferricin B (LF-B) demonstrated antifungal properties against several 
pathogenic yeasts and filamentous fungi. Candida tropicalis, Saccharomyces 
cerevisiae, Cryptococcus neoformans and Epidermophyton floccosum demonstrated 
low MIC values (0.31 to 2.5 µg/mL). However, most strains of non-pigmented 
hyphomycetes and zygomycetes were resistant to LF-B (MIC > 80 g/mL). 
